Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (231-240 of 492) with videos related to

Pageof 50
Sort By:
Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.
Bone Marrow Transplantation|January 23, 1999
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBTC Solano, C Martinez, S Brunet, et al.
Bone Marrow Transplantation|September 26, 2001
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantationR Martino, M D Caballero, C Canals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancerW D Foulkes, N Wong, J S Brunet, et al.
Leukemia & Lymphoma|July 28, 2016
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMTM Michallet, B Corront, L Molina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. ClassificationA López-Guillermo, J Cid, A Salar, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
Leukemia|December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Pérez-García, S Brunet, J J Berlanga, et al.
Leukemia|March 19, 2004
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationD Gallardo, R De la Cámara, A Torres, et al.
Bone Marrow Transplantation|October 21, 2014
Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCTA Bosch-Vizcaya, R Rodriguez-Romanos, J B Nieto, et al.
Pageof 50

Showing results (231-240 of 492) with videos related to

Sort By:
Pageof 50
Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.
Bone Marrow Transplantation|January 23, 1999
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBTC Solano, C Martinez, S Brunet, et al.
Bone Marrow Transplantation|September 26, 2001
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantationR Martino, M D Caballero, C Canals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancerW D Foulkes, N Wong, J S Brunet, et al.
Leukemia & Lymphoma|July 28, 2016
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMTM Michallet, B Corront, L Molina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. ClassificationA López-Guillermo, J Cid, A Salar, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
Leukemia|December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Pérez-García, S Brunet, J J Berlanga, et al.
Leukemia|March 19, 2004
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationD Gallardo, R De la Cámara, A Torres, et al.
Bone Marrow Transplantation|October 21, 2014
Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCTA Bosch-Vizcaya, R Rodriguez-Romanos, J B Nieto, et al.
Pageof 50